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Abstract
The oleoresin of Copaifera reticulata Ducke, Fabaceae, is a traditional Brazilian remedy used for a wide range of applications.
Commonly named copaiba, the oleoresin has been found to exhibit strong antimicrobial effects in our previous study, which
could be attributed to some of its diterpenoid constituents. In order to find new biological activities and to eventually enhance the
before observed effects, (−)-polyalthic acid (1) and kaurenoic acid (2), together with eight prepared semi-synthetic derivatives
(1a–1c and 2a–2e) were evaluated for their cytotoxic, antibacterial and antifungal properties. Regarding the gram-positive
bacteria Enterococcus faecium and methicillin-resistant Staphylococcus aureus, we found that both the exocylic methylene
group and the carboxyl group were crucial for the activity against these two clinically relevant bacterial strains. Investigation
of the antifungal activity, in contrast, showed that the carboxyl group is unnecessary for the effect against the dermatophytes
Trichophyton rubrum and Cryptococcus neoformans, indicated by low micromolar IC50 values for both (−)-polyalthic acid
diethylamide (1a) as well as (−)-polyalthic acid methyl ester (1b). Apart from studying the biological activity, the structure of
one semi-synthetic derivative, compound 1c, is being reported for the first time. During the course of the structure elucidation of
the new compound, we discovered inconsistencies regarding the stereochemistry of polyalthic acid and its stereoisomers, which
we clarified in the present work.
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Introduction
Copaiba, or copaiba oil, is the name of an oleoresin obtained
from selected species of the genus Copaifera, Fabaceae
(Leandro et al. 2012). Copaiba is widely used in the traditional
medicine in Brazil and other Latin American countries for
treatment of various diseases, such as skin and urinary tract
infections, respiratory diseases, ulcers, rheumatism, herpes,
tumours and tetanus disease (Ohsaki et al. 1994). Due to its
antibacterial, antihelminthic, trypanocidal and leishmanicidal
applications, the oleoresin represents an important natural
remedy for people without access to modern medicine and
commercial drugs (Ohsaki et al. 1994; Leandro et al. 2012).
Copaiba consists of sesquiterpenes and diterpenes, the
latter usually being present as diterpene acids (Leandro
et al. 2012). Sesquiterpenes represent the main com-
pounds that can count up to 98% of the oleoresin by
weight, and show a rather stable metabolite pattern, with
β-caryophyllene being the major constituent in most
Copaifera species (Leandro et al. 2012). However, β-
bisabolene has been identified as the major sesquiterpene
of Copaifera reticulata Ducke collected in the Pará region
(northern Brazil) (Pfeifer Barbosa et al. 2019). In contrast
to the sesquiterpenes, copaiba diterpenoids show much
higher interspecific variation and therefore attracted par-
ticular interest in recent years due to varying biological
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activities observed for the different Copaifera species
(Leandro et al. 2012). These activities comprise cytotoxic,
antibacterial, antifungal and antiprotozoal properties as
part of numerous in vitro and in vivo studies attempting
to attribute the detected effect to certain compounds or
compound classes.
The cytotoxic potential of the copaiba oleoresin seems
to mainly derive from its sesquiterpene constituents, as
respective investigations on diterpenoids resulted in weak
to moderate (but then non-selective) cytotoxic effects
(Cavalcanti et al. 2009; Pfeifer Barbosa et al. 2019). The
only exception is kolavenol, which showed antitumour
effects against IMC carcinoma in mice, determined by
an increase of life span of the animals (Ohsaki et al.
1994). In contrast, the main sesquiterpenes showed selective
moderate (β-bisabolol) to pronounced (β-caryophyllene and
β-caryophyllene oxide) cytotoxic activities (Kubo et al. 1996;
Yeo et al. 2016). With respect to their higher concentration in
the oleoresin, it is more likely that sesquiterpenes are respon-
sible for the antitumour properties of copaiba (Pfeifer Barbosa
et al. 2019).
On the other hand, copaiba diterpenoids showed good
in vitro activities against causative agents of infectious
parasitic diseases. Copalic acid, 3β-hydroxycopalic acid
and methyl copalate, for example, inhibited the growth
of the amastigote forms of Trypanosoma cruzi, whereas
kaurenoic acid (2) and some of its semi-synthetic deriva-
t ives were found active against i ts erythrocytic
trypomastigote forms (Vieira et al. 2002; Izumi et al.
2012). (−)-Polyalthic acid (1), another major copaiba
diterpenoid showed activity against T. brucei and
amastigote forms of Leishmania donovani (Mizuno et al.
2015). Also here, semi-synthetic derivatives were pre-
pared, of which some showed comparable to slightly
higher activities than the natural product. However, nei-
ther (−)-polyalthic acid (1) nor any of its derivatives was
leishmanicidal against promastigote forms of L. donovani.
Moreover, copaiba diterpenoids revealed antibacterial ac-
tivity against both gram-positive and gram-negative bacteria,
with pronounced effects against Bacillus subtilis and five dif-
ferent Streptococcus species (Tincusi et al. 2002; Souza et al.
2011). In our previous study, we reported strong inhibitory
effects against the two clinically relevant bacterial strains
methicillin-resistant Staphylococcus aureus (MRSA) and
Enterococcus faecium for three diterpene acids, of which
one was kaurenoic acid (2) (Pfeifer Barbosa et al. 2019). In
the same study, antidermatophytic activity against two
Trichopyhton species was detected for (−)-polyalthic acid
(1), the major diterpenoid in the Copaifera reticulata oleores-
in, along with weak [(−)-polyalthic acid, 1] to moderate
(kaurenoic acid, 2) cytotoxic effects against six cancer cell
lines. These findings prompted us to prepare semi-synthetic
derivatives of both compounds in an attempt to enhance their
antimicrobial and cytotoxic properties and to get more insights
into their structure-activity-relationships (SAR). Furthermore,
additional screenings were performed to discover new lead
compounds against both human and plant pathogens.
Materials and Methods
Plant Material and Chemicals
(−)-Polyalthic acid (1) and kaurenoic acid (2) were isolated
from the oleoresin of Copaifera reticulata Ducke, Fabaceae,
as described in our previous studies (Çiçek et al. 2018; Pfeifer
Barbosa et al. 2019). N-Chlorosuccinimide (98%) and
triphenylphosphine (ReagentPlus, 99%), sulphuric acid
(puriss., analytical grade) and LC-MS grade formic acid were
purchased from Sigma-Aldrich Co., St. Louis, MO, USA.
Hydrochloric acid (25%, analytical grade) was obtained from
Honeywell, Seelze, Germany, while sodium hydroxide solu-
tion (2N) was purchased from Carl Roth GmbH, Karlsruhe,
Germany. Diethylamine (for synthesis), acetone (analytical
grade), methanol (gradient grade or LC-MS grade) and water
(LC-MS grade) as well as other analytical grade solvents used
for purification were obtained from VWR International
GmbH, Darmstadt, Germany. Solid phase extraction (SPE)
columns (Chromabond SB 3 ml/500 mg) were obtained from
Macherey-Nagel GmbH & Co. KG, Düren, Germany.
Deuterated methanol (Lot P3021, 99.80%), deuterated
DMSO (Lot S1051, 99.80%) and deuterated chloroform
(Lot Q1981, 99.80%) for NMR spectroscopy were obtained
from Eurisotop GmbH, Saarbrücken, Germany. Conventional
5-mm sample tubes were purchased from Rototec-Spintec
GmbH, Griesheim, Germany.
General Experimental Procedures
Semi-synthetic derivatives of compounds 1 and 2 were
prepared in 5-ml V-Vials (Wheaton, Millville, NJ, USA)
using a RET basic magnetic stirrer with integrated heater
(IKA-Werke GmbH & Co. KG, Staufen, Germany). LC-
DAD-ELSD analysis was accomplished as stated in Çiçek
et al. (2018); LC-MS and GC-MS analyses were conduct-
ed as described in Pfeifer Barbosa et al. (2019). High-
resolution MS spectrum was recorded on micrOTOF II-
High-performance TOF-MS system (Bruker®, Billerica,
MA, USA) equipped with an electrospray ionisation
source. Specific rotation of the compounds measured in
methanol on a Jasco P-2000 polarimeter (Jasco,
Pfungstadt, Germany). NMR spectra were recorded using
a Bruker Avance III 400 NMR spectrometer operating at
400 MHz for the proton channel and 100 MHz for the 13C
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channel with a 5 mm PABBO broad band probe with a z
gradient unit at 293 K (Bruker BioSpin GmbH,
Rheinstetten, Germany). Reference values were 3.31
(1H) and 49.15 ppm (13C) for methanol as well as 2.50
(1H) and 39.51 ppm (13C) for DMSO, respectively.
Preparation of Derivatives
Carboxyl Amides
The compound (100 μmol) and triphenylphosphine were dis-
solved in 2 ml of dichloromethane, and the mixture was cooled
in an ice bath. After adding 110 μmol of N-chlorosuccinimide in
small portions, the mixture was vigorously stirred for 30 min at
room temperature. Diethylamine (110 μmol) in 100 μmol of
pyridine was added, and the mixture was stirred for another
10 min at room temperature. The mixture was subsequently con-
centrated under reduced pressure, and the by-products were re-
moved by filtration and solid phase extraction using hexane as
solvent to afford 6.2 mg of (−)-polyalthic acid-N,N-diethylamide
(1a) and 7.5 mg kaurenoic acid-N,N-diethylamide (2a).
Carboxyl Esters
The formation of ester was accomplished in the same manner
except that diethylamine was substituted with methanol in the
last reaction step. This reaction yielded 4.2 mg (−)-polyalthic
acid methyl ester (1b) and 7.3 mg kaurenoic acid methyl ester
(2b).
Dihydroxy Derivatives
The compound (100 μmol) was dissolved under heating in a
mixture of 800μl of water and 200μl of 2M sodium hydroxide.
The solution was subsequently cooled to 5 °C, and 250mg of ice
was added before adding a cold solution of 20.5 mg potassium
permanganate in 500 μl of water over a period of 30 min. The
mixture was kept at 0 to 5 °C for another 60 min before the
precipitate was filtered off andwashedwith hotwater. The filtrate
was acidified with acetic acid, and the resulting precipitate was
filtered of and washedwith cold water and dried to afford 8.8 mg
of (4S,8S)-15,16-epoxy-8,17-dihydroxy-13(16),14-ent-
labdadien-18-oic acid [(1S,4aR,5S,6S,8aS)-5-[2-(furan-3-
yl)ethyl]-1,4a-dimethyl-6-hydroxy-6-hydroxymethyl-
3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid] (1c)
and 13.0 mg of 16α,17-dihydroxy-ent-kauran-19-oic acid (2c),
respectively, after recrystallisation from a mixture of hexane and
tert-butyl methyl ether.
Monohydroxy Derivative
Compound 2 (50 mg) was dissolved in a mixture of 1500 μl
acetone, 350 μl water and 150 μl hydrochloric acid (25%) and
kept at 56 °C for 2 h under stirring. The solution was then
transferred to a beaker containing 10 ml of water ,and the
resulting precipitate was filtered and recrystallised from ace-
tone to obtain 12.2 mg of 16α-hydroxy-ent-kauran-19-oic ac-
id (2d).
Methoxy Derivative
Compound 2 (50 mg) was dissolved in a mixture of
2500 μl methanol and 150 μl sulphuric acid and kept at
65 °C for 3 h under stirring. The solution was subsequent-
ly cooled to − 18 °C and the resulting precipitate was
filtered and recrystallised from methanol to obtain
7.9 mg of 16α-methoxy-ent-kauran-19-oic acid (2e).
Biological Activity Testing
Antibacterial and Antiyeast Activity
The samples were tested against the ESKAPE panel of multi-
drug resistant bacterial human pathogens, including the gram-
positive bacteria Enterococcus faecium (DSM 20477) and
methillicin-resistant Staphylococcus aureus (MRSA, DSM
18827), and the gram-negative bacteria Klebsiella
pneumoniae (DSM 30104), Acinetobacter baumannii (DSM
30007), Pseudomonas aeruginosa (DSM 1128) and
Escherichia coli (DSM 1576). Furthermore the activity of
the samples against four phytopathogenic bacteria,
Pseudomonas syringae (DSM 50252), Xanthomonas
campestris (DSM 2405), Erwinia amylovora (DSM 50901)
and Ralstonia solanacearum (DSM 9544), and against two
human pathogen yeasts, Candida albicans (DSM 1386) and
Cryptococcus neoformans (DSM 6973), was carried out. All
test strains were purchased from Leibniz Institute DSMZ-
German Collection of Microorganisms and Cell Cultures,
Braunschweig, Germany.
The bacteria were cultivated in TSB medium (1.2% tryp-
tic soy broth, 0.5% NaCl), except E. faecium which was
cultivated in M92 medium (3% trypticase soy broth, 0.3%
yeast extract, pH 7.0–7.2) and R. solanacearum which was
grown in M186 (1% glucose, 0.5% peptone from soymeal,
0.3% malt extract, 0.3 yeast extract). The cultivation of
C. albicans took place in M186/3 (0.3% glucose, 0.17%
peptone from soymeal, 0.1% malt extract, 0.1% yeast ex-
tract) and for C. neoformans M186 was used as well.
Overnight cultures of the test organisms were prepared
and diluted to an optical density (600 nm) of 0.01–0.03.
To prepare the assay, the test samples (20 mg/ml DMSO
stock solution) were dissolved in medium and transferred
into a 96-well microtiter plate and 200 μl of the cell suspen-
sion cultures was added to each well. The final assay con-
centration of the substances was 100 μg/ml. The inoculated
microplates were incubated for 5 h at 37 °C and 200 rpm
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(E. faecium without shaking), or 28 °C and 200 rpm for 7 h
for the phytopathogen bacteria and C. neoformans, respec-
tively. To detect the inhibitory effect of the substances 10 μl
of a resazurin solution (0.3 mg/ml phosphate-buffered sa-
line) was added to the microplates and incubated again for
5–30 min before the fluorescence signal (560 nm/590 nm)
was measured using the microplate reader (Tecan Infinite
M200). For E. faecium the pH indicator bromocresol purple
was used to determine the acidification caused by growing,
and for R. solanacearum and C. neoformans the optical
density at 600 nm after incubation time was recorded using
the microplate reader as well. The resulting values were
compared with a positive control (chloramphenicol for the
bacteria, except R. solanacearum where tetracycline was
used, nystatin for C. albicans and amphotericin B for
C. neoformans) and a negative control (no compound) on
the same plate. For IC50 determination, a dilution series was
prepared and the IC50 value was calculated by Excel or
GraphPad Prism as the concentration that shows 50% inhi-
bition of viability on the basis of a negative control (no
compound).
Cytotoxic Activity and Activity Against Dermatophytic Fungi
Measurements of cytotoxic activity and activity against
dermatophytic fungi were performed as described in our pre-
vious study (Pfeifer Barbosa et al. 2019).
Results and Discussion
Preparation of Semi-synthetic Derivatives 1a–1c
and 2a–2e
Semi-synthetic derivatives of (−)-polyalthic acid (1) and
kaurenoic acid (2) were prepared on a small scale using 5-ml
V-Vials and applying between 30 and 50mg of diterpene acid.
Derivatisations included the carboxyl group and the exocyclic
methylene group, respectively. Thus, N,N-diethyl amide (1a
and 2a) and methyl ester (1b and 2b) as well as dihydroxy
derivatives (1c and 2c) of both parent molecules were pre-
pared as described in the Experimental section. Additionally,
one monohydroxy derivative (2d) and one methoxy derivative
(2e) of kaurenoic acid were prepared. All products were
analysed by TLC using different mixtures of dichloromethane
and ethanol as solvent and vanillin-sulphuric acid as spray
reagent. Amides and esters were additionally checked by
GC-MS2, whereas the other derivatives were analysed by
UHPLC-DAD/ELSD and UHPLC-MS2. For structure eluci-
dation, one- and two-dimensional NMR experiments were
performed.
Amides and Methyl Esters
Amidation and esterification of diterpenoids was accom-
plished using N-chlorosuccinimide and triphenylphosphine
for conversion of the carboxylic acids and adding either
N,N-diethylamine or methanol in pyridine to the reaction mix-
ture as described in the protocols of Frøyen (1994, 1995). The
experiments were therefore downsized to 100 μmol of reac-
tants (instead of 5 mmol) except for dichloromethane, of
which 2 ml (instead of 6 ml) was used. Purification was con-
ducted as described in the protocols (concentration, filtration
and washing with diethyl ether, silica gel column with ether as
eluent). However, for the last purification step another silica
gel column with n-hexane as eluent was preferred over
crystallisation or distillation, respectively. All four derivatives
were subsequently analysed by GC-MS2 showing the expect-
edm/z ratios of 371 (1a), 357 (2a), 330 (1b), and 316 (2b) and
by NMR spectroscopy comparing their spectra to literature
data (Narayanan and Venkatasubramanian 1965; Vieira et al.
2002; Mizuno et al. 2015; Santos et al. 2016). The methyl
esters (1b and 2b) were additionally identified by comparing
their mass spectra to the spectra available in the NIST
database.
Dihydroxy Derivatives
Dihydroxy derivatives of compounds 1 and 2 were prepared
with potassium permanganate in alkaline medium following a
protocol for the hydroxylation of lambertianic acid (Chernov
et al. 2006). Lambertianic acid is an epimer of (+)-polyalthic
acid at position C-4 and thus a stereoisomer of (−)-polyalthic
acid (1), showing different configurations at positions C-5,
C-9, and C-10. Using scales of 100 μmol of diterpenoid in-
stead of 20 mmol, the reaction yielded (4S,8S)-15,16-epoxy-
8,17-dihydroxy-13(16),14-ent-labdadien-18-oic acid (1c), a
previously undescribed compound, and the known compound
16α,17-dihydroxy-ent-kauran-19-oic acid (2c). Whereas the
latter compound was identified by comparison of MS and
NMR spectra to literature data (Song et al. 2018), structure
elucidation of compound 1c is described in “Structure
Elucidation and Configuration of Compound 1c”.
Monohydroxy and Methoxy Derivatives
Preparation of 16α-hydroxy-ent-kauran-19-oic acid (2d),
16α-methoxy-ent-kauran-19-oic acid (2e) was performed
using acid-catalysed hydroxylation and methoxylation,
respectively (Cavalcanti et al. 2009). For these reac-
tions, amounts of 50 mg were applied instead of 1 g
and the resulting products were identified by compari-
son of their MS and NMR data to literature (Chen et al.
2000; Yaouba et al. 2018).
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Structure Elucidation and Configuration
of Compound 1c
As mentioned above, compound 1cwas synthesised using a
protocol (Chernov et al. 2006) reported for the transforma-
tion of lambertianic acid, a stereoisomer of (−)-polyalthic
acid (1). The side chain at C-10 of lambertianic acid is β-
oriented leading to α-oriented hydroxylation at position
C-8, due to steric hindrance by the furanoethyl group. In
contrast, (−)-polyalthic acid (1) shows an α-oriented side
chain at C-10; hence, the resulting hydroxy group at position
C-8 had to have β-orientation and the hydroxymethylene
group α-orientation instead. The α-orientation of the
hydroxymethylene group was confirmed using NOESY,
where NOE correlations were observed for the protons at
C-17 on both the methylene group at C-11 and the C-20
methyl group. Thus, the structure was identified as (4S,8S)-
15,16-epoxy-8,17-dihydroxy-13(16),14-ent-labdadien-18-
oic acid or (rel-1S,4aR,5S,6S,8aS)-5-[2-(furan-3-yl)ethyl]-
1,4a-dimethyl-6-hydroxy-6-hydroxymethyl-3,4,5,7,8,8a-
hexahydro-2H-naphthalene-1-carboxylic acid, respectively
(see “Stereochemistryof PolyalthicAcid,DaniellicAcid and
Lambertianic Acid”). Same as (−)-polyalthic acid (1), the
new compound (1c) showed a negative specific rotation
value [αD
20–14.9, c = 0.1, methanol). HR-ESI-MS re-
vealed m/z ratios of 373.1994 [M + Na]+ and 723.4090
[2 M + Na]+, corresponding to the molecular formula
C20H30O5 with the experimental mass of M 350.2096
(calculated mass was M 350.2093). NMR data for com-
pound 1c is given in Table 1.
Stereochemistry of Polyalthic Acid, Daniellic Acid
and Lambertianic Acid
As described above, hydroxylation of (−)-polyalthic acid (1)
followed a protocol of Chernov et al. (2006), who used
lambertianic acid as starting material. However, during the
course of the structure determination of compound 1c and
assignment of the absolute configuration, some inconsis-
tencies have been observed with regard to the stereochemistry
of polyalthic acid and its structural isomers, which we
attempted to resolve hereafter.
Rev. Bras. Farmacogn. (2020) 30:18–2722
The first two of these four compounds to be reported were
(−)-polyalthic acid (1) and daniellic acid in 1961. As the ab-
solute configuration has not been determined yet, (−)-
polyalthic acid is correctly described as (rel-1S,4aS,5R,8aS)-
5-[2-(furan-3-yl)ethyl]-1,4a-dimethyl-6-methylene-
decahydronaphthalene-1-carboxylic acid. Daniellic acid was
isolated from Daniellia oliveri (Fabaceae, Caesalpinioideae)
(Haeuser and Ourisson 1961), whereas (−)-polyalthic acid (1)
was obtained from Polyalthia fragrans (Annonaceae) and
named polyalthic acid (Gopinath et al. 1961). Both com-
pounds were attributed to possess the “wrong” configuration
corresponding to an ent-labdane scaffold and showing nega-
tive optical rotation values. Both compounds are epimers, on-
ly differing in the orientation of the carboxyl group at position
C-4, which is axial for daniellic acid and equatorial for (−)-
polyalthic acid (1). Five years later, the first report for
lambertianic acid, isolated from Pinus lambertiana
(Pinaceae), was made (Dauben and Dauben and German
1965). Lambertianic acid was found to be the optical antipode
of daniellic acid and thus to be the first furan diterpene with
the so-called normal labdane configuration. The last of the
four isomers was the optical antipode of (−)-polyalthic acid
(1), isolated from Sequoia semperivirens, Taxodiaceae (Ohta
and Nawamaki 1978). However, instead of choosing an orig-
inal trivial name (e.g. semperiviric acid), the authors named
the compound (+)-polyalthic acid, being (rel-1R,4aR,5S,8aR)-
5-[2-(furan-3-yl)ethyl]-1,4a-dimethyl-6-methylene-
decahydronaphthalene-1-carboxylic acid. Thus, from then on-
wards, two forms of polyalthic acid existed in the literature.
Except for the last 3 years, where (+)- and (−)- or ent- prefixes
were used to differentiate between the two enantiomers
(Bardají et al. 2016; Borges et al. 2016; Carneiro et al. 2018;
Çiçek et al. 2018; Pfeifer Barbosa et al. 2019; Senedese et al.
2019), only one publication in almost four decades adopted
such prefixes (Miyazawa et al. 1995). The missing stereo-
chemistry did not represent a problem as long as the studies
were dealing with Copaifera, because the ent-configuration is
abundant in this genus (Leandro et al. 2012). However, some
Table 1 NMR data for
compound 1c in methanol-d4 and
DMSO-d6 (400 MHz, δ in ppm, J
in Hz)
Position 1H NMR (CD3OD)
13C NMR (CD3OD)
1H NMR (DMSO-d6)
13C NMR (DMSO-d6)
1 1.77 (m) 41.0 1.63 (m) 38.4
1.14 (m) 0.97 (m)
2 1.68 (m) 19.1 1.54 (m) 16.8
1.59 (m) 1.46 (m)
3 2.24 (m) 38.7 2.06 (m) 36.8
1.29 (m) 1.06 (m)
4 48.6 46.4
5 1.89 (s) 50.3 1.68 (s) 49.9
6 1.47 (m) 24.4 1.31 (m) 22.0
1.27 (m) 1.05 (m)
7 1.81 (m) 38.8 1.64 (m) 36.1
1.58 (m) 1.45 (m)
8 76.8 74.4
9 1.42 (s) 62.8 1.25 (s) 60.6
10 39.7 37.6
11 1.87 (m) 27.5 1.74 (m) 25.0
1.46 (m) 1.30 (m)
12 2.63 (m) 29.9 2.35 (m) 27.5
2.48 (td, 12.1, 3.9) 2.06 (m)
13 126.1 125.6
14 6.35 (d, 0.9) 112.5 6.36 (d, 0.8) 111.3
15 7.39 (t, 1.4) 144.2 7.53 (t, 1.5) 142.8
16 7.30 (s) 140.3 7.42 (s) 138.6
17 3.65 (d, 10.8) 64.1 3.38 (d, 10.7) 61.3
3.51 (d, 7.9) 3.27 (d, 10.7)
18 n.o. 180.6
19 1.16 (s) 17.5 1.01 (s) 16.0
20 0.85 (s) 17.3 0.72 (s) 15.5
n.o., not observed
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studies investigated plant species from other plant families;
wherefore, the identity of the right enantiomer remained un-
known. Thus, reporting the right configuration for polyalthic
acid is absolutely necessary.
Another problem is that the introduction of (+)-polyalthic
acid and the recent use of the ent-prefix for differentiation of
the enantiomers seems to have caused confusions in some
large databases, such as SciFinder™ or Reaxys™. For exam-
ple, when searching for structure templates of polyalthic acid
in the Reaxys database, three suggestions are delivered, of
which two display (−)-polyalthic acid and the other one shows
(+)-polyalthic acid. However, by using the name ent-
polyalthic acid, also two structures are displayed, one for
(−)-polyalthic acid and the second one for daniellic acid. For
both compounds their semisystematic names are given along
with twelve references per compound, thus giving equal pri-
ority to the correct and the incorrect structure. By looking for
chemical structures in the SciFinder database, the name
polyalthic acid leads to the structure of (−)-polyalthic acid,
which is historically correct, whereas the search for ent-
polyalthic acid gives the structure of daniellic acid and thus
the wrong compound. Alas, these inconsistencies or confu-
sions, respectively, led to several publications showing the
structure of daniellic acid instead of (−)-polyalthic acid
(Leandro et al. 2012, Çiçek et al. 2018, Da Silva et al. 2017;
Pfeifer Barbosa et al. 2019). The mentioned problems can be
partly dealt with by using the prefixes of the respective optical
rotations, leading to the exact structures for both (+)- and (−)-
polyalthic acid in the Reaxys database and also to the correct
structure for (+)-polyalthic acid with the SciFinder database.
Only the name (−)-polyalthic acid does not yield any results
with SciFinder, but as the name polyalthic acid leads to the
structure of (−)-polyalthic acid and the optical rotation can be
retrieved from the experimental details, at least no misinfor-
mation is spread. We therefore suggest to use the prefix for the
optical rotation only.
Cytotoxic Effects
In our previous study, we investigated the effect of copaiba
diterpenoids against A-375, HepG2, HT-29, HCT-116, A-549
and MDA-MB-231 cancer cell lines as well as non-cancerous
HaCaT cell lines resulting in weak to moderate non-selective
cytotoxic effects with IC50 values of 66.2 to 96.4 μg/ml for
(−)-polyalthic acid (1) and 50.2 to 79.6 μg/ml for kaurenoic
acid (2) (Pfeifer Barbosa et al. 2019). Thus, the effect of
derivatising either the carboxyl group or the exocyclic meth-
ylene group was the main aim of the present study. In a first
screening at a concentration of 100 μg/ml no effects for de-
rivatives without the exocyclic methylene group (1c and 2c–
2e) were observed (Table S1). Compounds 2d and 2e were
earlier tested on four different cancer cell lines (K562, HL-60,
MDA-MB435 and SF295) as well as on healthy peripheral
blood mononuclear cells and compared with kaurenoic acid
(Cavalcanti et al. 2009). Also here, the cytotoxic effect disap-
peared after derivatisation; wherefore, the authors
hypothesised that the exocyclic methylene group is crucial
for the cytotoxic effect.
However, also derivatisation of the carboxyl group (com-
pounds 1a, 1b, 2a and 2b) did not result in total growth inhi-
bition at 100 μg/ml, but rather affected healthy HaCaTcells at
this concentration. Because of the only low cytotoxic activity
of compounds 1 and 2 found in our previous study and the not
too promising results of the preliminary screening, we decided
to focus on the antimicrobial effects of our compounds.
Antibacterial Effects
Due to the strong effects of (−)-polyalthic acid (1) and espe-
cially kaurenoic acid (2) against E. faecium and methicillin-
resistant Staphylococcus aureus (MRSA) (Pfeifer Barbosa
et al. 2019), additional assays on Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa and
Escherichia coli as well as phytopathogens Pseudomonas
syringae, Xanthomonas campestris, Erwinia amylovora and
Ralstonia solanacearum were included in our investigations
(Table S2). However, at a concentration of 100 μg/ml, activity
of compounds 1 and 2 as well as their derivatives against the
additionally investigated organisms was rather low or non-
existent in contrast to the already known effects against
E. faecium and MRSA. But also against the latter two strains
derivatisations did not lead to an improved activity (Table 2).
Here, only compound 2c showed (at least moderate) effects,
with IC50 values of 59.7 μg/ml against E. faecium and
34.7 μg/ml against MRSA. In contrast, (−)-polyalthic acid
(1) and kaurenoic acid (2) showed IC50 values of 8.5 and
2.3 μg/ml against E. faecium as well as 8.9 and 3.4 μg/ml
Table 2 Antibacterial effects of (−)-polyalthic acid (1), kaurenoic acid
(2) and their derivatives. The IC50 values are in μg/ml. Positive controls
were ampicillin (Enterococcus faecium) and chloramphenicol (MRSA)
E. faecium MRSA
Compound 1 8.5 ± 0.4 8.9 ± 0.8
Compound 1a > 100 > 100
Compound 1b > 100 > 100
Compound 1c > 100 > 100
Compound 2 2.3 ± 0.2 3.4 ± 0.2
Compound 2a > 100 > 100
Compound 2b > 100 > 100
Compound 2c 59.7 ± 0.1 34.7 ± 2.5
Compound 2d > 100 > 100
Compound 2e > 100 > 100
Positive control 0.4 ± 0.1 1.2 ± 0.1
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against MRSA, respectively. Thus, both the carboxyl group
and the exocyclic methylene group seem to be pivotal for the
activity against these two clinically relevant strains.
Antifungal Effects
(−)-Polyalthic acid (1) was the most potent compound against
Trichopyhton species dermatophytes in our previous study,
with IC50 values of 6.8 μg/ml against T. rubrum and
4.3 μg/ml against T. mentagrophytes, respectively (Pfeifer
Barbosa et al. 2019), while kaurenoic acid (2) only showed
weak (70.8 μg/ml) to moderate effects (15.5 μg/ml) against
these two strains (Table 3). Derivatisation of the two natural
products this time revealed a different picture, leading to one
equally potent (1b) and another still moderately active com-
pound (1a) against T. rubrum, with IC50 values of 7.7 μg/ml
for (−)-polyalthic acid methyl ester (1b) and 13.8 μg/ml for
(−)-polyalthic acid N,N-diethylamide (1a), respectively.
Notably, this effect was not observed against T.
mentagrophytes, where the IC50 value was increased by the
factor five. For kaurenoic acid (2), a similar picture was ob-
served. Here, amidation (2a) and esterification (2b) yielded
even more active compounds against T. rubrum, though on an
overall higher level. Still, also against T. mentagrophytes the
activity was drastically reduced by derivatisation of the car-
boxyl group. Of the remaining derivatives, only compound 1c
showed activity, with an IC50 of 61.8 μg/ml against T. rubrum
and 31.9 μg/ml against T. mentagrophytes.
The compounds were furthermore investigated for their
inhibitory potential against two yeasts, Candida albicans
and Cryptococcus neoformans. While the activity against
C. albicans was negligible (Table S3), the results against
C. neoformans revealed interesting findings for compounds
1, 1a and 1b. All three compounds showed similar IC50
values, which were in the range of 9.5 to 11.2 μg/ml
(Table 3). However, below this concentrations the activity of
(−)-polyalthic acid (1) decreased rapidly in contrast to its two
non-acidic derivatives (1a and 1b) (Fig. 1).
Conclusion
(−)-Polyalthic acid (1) and kaurenoic acid (2) as well as their
semi-synthetic derivatives (1a–1c and 2a–2e) were investigat-
ed for their cytotoxic, antibacterial and antifungal properties,
with different outcomes. While the previously discussed im-
portance of an exocyclic methylene group for the cytotoxic
effect was also apparent in our study, we furthermore found
that both the exocyclic methylene and the carboxylic acid
group were necessary for the effect against E. faecium and
MRSA.
However, different results were obtained with regard to the
antifungal activity of the two natural products and their deriv-
atives. For T. mentagrophytes, the picture was somehow sim-
ilar to the antibacterial assays, where the best antifungal activ-
ity was achieved when both an exocylic methylene group and
a carboxylic acid were present. In contrast, the presence of an
carboxyl group was not required for activity against
C. neoformans and T. rubrum, as displayed by the similar
IC50 values of 1, 1a and 1b. However, the low IC50 value of
compound 1c clearly shows that at least the methylene group
is crucial for the effect.
Besides gaining further insights into differential biological
activities and some SARs for copaiba diterpenoids, we present
a novel semi-synthetic derivative of (−)-polyalthic acid. In the
course of verifying the relative configuration of the new com-
pound, we discovered ambiguities regarding the stereochem-
istry of polyalthic acid by two commonly used databases,
which also led to incorrect chemical structures in several pub-
lications. We thus suggest to only use the terms (+)- and (−)-
Table 3 Antifungal effects of (−)-polyalthic acid (1), kaurenoic acid (2)
and their derivatives. The IC50 values are in μg/ml. Positive controls were
clotrimazole (Trichophyton rubrum and T. mentagrophytes) and
amphotericin B (Cryptococcus neoformans)
T. rubrum T. mentagrophytes C. neoformans
Compound 1 6.8 ± 0.1 4.3 ± 0.1 11.2 ± 0.3
Compound 1a 13.8 ± 3.0 23.5 ± 0.6 9.5 ± 0.4
Compound 1b 7.7 ± 0.6 21.8 ± 0.9 11.0 ± 4.9
Compound 1c 61.8 ± 1.3 31.9 ± 1.6 > 100
Compound 2 70.8 ± 1.6 15.5 ± 0.7 > 100
Compound 2a 51.5 ± 7.0 > 100 > 100
Compound 2b 53.0 ± 6.2 > 100 > 100
Compound 2c > 100 > 100 > 100
Compound 2d > 100 > 100 > 100
Compound 2e > 100 > 100 > 100
Positive control 0.1 ± 0.0 0.1 ± 0.0 0.6 ± 0.1 Fig. 1 IC50 curves compounds 1, 1a and 1b against Cryptococcus
neoformans
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polyalthic acid to differentiate between the two enantiomers in
order to hopefully avoid such mistakes in future publications.
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